Glioblastoma multiforme is the most aggressive and common primary brain tumor in adults, with rapid growth that invades nearby brain tissue and a devastating impact on survival—yet understanding its nature and treatment options can help patients and families navigate this challenging diagnosis.
Understanding Glioblastoma Multiforme
Glioblastoma, also called glioblastoma multiforme or GBM, is a grade IV astrocytoma, which means it is the most severe and fast-growing type of tumor that originates in the brain’s supporting cells. These tumors start in star-shaped cells called astrocytes, which normally help support nerve cells and carry nutrients to them. Unlike many other cancers, glioblastoma generally does not spread to distant organs but instead invades the nearby brain tissue aggressively, making it extremely difficult to remove completely through surgery.[1][2]
The term “multiforme” reflects the mixed appearance of the tumor, which contains abnormal astrocytic cells along with other cell types, blood vessels, and areas of dead tissue called necrosis. The tumor grows and spreads so quickly that it can result in death within six months if left untreated. Even with aggressive treatment, glioblastoma remains one of the most challenging cancers to manage, as it infiltrates healthy brain tissue with hairlike tentacles that make complete surgical removal nearly impossible.[3][4]
Glioblastomas are classified as primary or secondary. Primary GBM develops directly from glial cells without warning, while secondary GBM evolves from a lower-grade tumor over time. Most cases are primary, and these patients tend to be older and have a poorer outlook than those with secondary tumors. The tumor can arise spontaneously in the brain, or in rare cases, transform from a previously existing lower-grade tumor.[3]
How Common Is Glioblastoma?
Glioblastoma is the most common malignant brain tumor in adults, accounting for approximately 45 to 48 percent of all primary malignant brain and central nervous system tumors. Despite being rare compared to other cancers, it affects thousands of people each year. In the United States, more than 13,000 people are diagnosed with GBM annually, with an incidence rate of about 3.2 cases per 100,000 people in the population.[1][2]
The disease most commonly affects adults between the ages of 45 and 70, with the median age at diagnosis being 64 years. Glioblastoma is more frequently diagnosed in men than in women, with a ratio of approximately 1.6 men for every 1 woman. The disease is also more common in Caucasians compared to other ethnic groups. While it can occur in younger individuals and even children, it remains relatively rare in these age groups.[1][4]
The tumor most often develops in the cerebral hemispheres, which are the largest parts of the brain located directly behind the forehead and near the temples. Specifically, glioblastomas are frequently found in the frontal and temporal lobes, though they can also appear in the parietal and occipital lobes, as well as less commonly in the brainstem or spinal cord.[1][6]
What Causes Glioblastoma?
The exact cause of glioblastoma remains largely unknown. Scientists believe that changes in the genetic material (DNA) within brain cells lead to uncontrolled cell growth and the formation of tumors. These genetic mutations cause cells to multiply out of control and destroy healthy brain tissue. The mutations happen to specific genes that normally control how cells grow and divide, but when these genes are damaged, the cells lose their ability to regulate themselves.[3][5]
While most cases of glioblastoma occur randomly without an identifiable cause, researchers have identified several genetic alterations within tumor cells. Advanced research has revealed more than 600 genes that may be involved, affecting three core signaling pathways commonly activated in glioblastoma. Despite this knowledge, the trigger that initiates these changes in otherwise normal brain cells is still not fully understood.[2][10]
The majority of glioblastomas develop spontaneously during a person’s lifetime, meaning the genetic mutations are not inherited from parents. Inherited GBMs are extremely rare. However, certain inherited genetic conditions can significantly increase the risk of developing this tumor. These include Li-Fraumeni syndrome, Lynch syndrome, neurofibromatosis, and Turcot syndrome. People with these conditions have mutations passed down from their biological parents that make them more vulnerable to developing brain tumors.[1][3]
Risk Factors for Developing Glioblastoma
While most people diagnosed with glioblastoma have no identifiable risk factors, certain exposures and conditions have been linked to an increased likelihood of developing the disease. The only well-established environmental risk factor is exposure to high doses of ionizing radiation, particularly therapeutic radiation to the head or brain. People who received radiation therapy as children or for previous medical conditions have a higher lifetime risk of developing glioblastoma later in life.[1][2]
Age is one of the most significant risk factors. Glioblastoma occurs most frequently in adults between 45 and 70 years old, though it can develop at any age. Gender also plays a role, as men are diagnosed with glioblastoma more often than women. Ethnicity is another factor, with Caucasian individuals having a higher incidence compared to other racial and ethnic groups.[1][4]
Some research suggests that exposure to certain chemicals may increase risk. These include pesticides, petroleum products, synthetic rubber, and vinyl chloride. However, the evidence for these environmental exposures is not as strong as it is for radiation. Interestingly, some studies have indicated that people with seasonal allergies, such as hay fever, may have a lower risk of developing glioblastoma, possibly due to a heightened immune system response, though this protective effect is not fully understood.[3]
Recognizing the Symptoms of Glioblastoma
Glioblastoma symptoms develop because the growing tumor puts pressure on the brain and destroys healthy tissue. The symptoms depend heavily on where in the brain the tumor is located. For example, if the tumor grows in an area that controls arm movement, weakness in the arm may develop. If it affects the speech centers, difficulty forming words becomes apparent. Symptoms often appear gradually at first but tend to worsen rapidly as the tumor grows.[1][5]
One of the most common early symptoms is persistent headaches, which may be the first sign of a problem. These headaches are often different from typical headaches and may worsen over time. As the tumor increases in size, it raises the pressure inside the skull, a condition called increased intracranial pressure, which leads to additional symptoms such as nausea, vomiting, and loss of appetite.[1][3]
Other common symptoms include seizures, which may occur suddenly in someone with no prior history of epilepsy. Vision problems are also frequent, including blurred vision, double vision, or gradual loss of sight. Memory problems, difficulty concentrating, and changes in the ability to think clearly can develop as the tumor affects cognitive areas of the brain. Personality and mood changes, including irritability, confusion, or inappropriate behavior, may also occur.[1][3]
Physical symptoms can include muscle weakness, balance problems, difficulty walking, and changes in sensation such as numbness or tingling. Some people experience speech difficulties, either trouble speaking or understanding language. Fatigue and drowsiness are also common. In advanced cases, symptoms may resemble a stroke, with sudden weakness on one side of the body or loss of consciousness.[3][5]
Because these symptoms can be caused by many other health conditions, it is important not to assume they are due to a brain tumor. However, any new, persistent, or worsening neurological symptoms should be evaluated promptly by a healthcare provider. Early diagnosis can make a significant difference in managing the disease and improving quality of life.[3]
How Is Glioblastoma Diagnosed?
Diagnosing glioblastoma begins with a thorough medical history and a neurological examination. During this exam, a healthcare provider checks vision, hearing, balance, coordination, strength, and reflexes. Problems in any of these areas can provide clues about which part of the brain is affected by the tumor. The examination also includes assessments of memory, speech, and cognitive function.[1][8]
If a brain tumor is suspected, imaging tests are essential for locating and evaluating the tumor. Magnetic resonance imaging (MRI) is the most important and commonly used imaging study for diagnosing glioblastoma. MRI scans are typically performed both with and without an intravenous dye called contrast, which makes the tumor more visible. On MRI images, glioblastomas usually show strong contrast enhancement, meaning the tumor appears bright, along with a dark central area due to necrosis and surrounding swelling of the brain tissue.[1][8]
Other imaging techniques can provide additional information. Computed tomography (CT or CAT scan) can help pinpoint the tumor’s location, especially when MRI is not available or cannot be performed. Magnetic resonance spectroscopy (MRS) examines the chemical composition of the tumor by measuring levels of specific chemicals in the brain. This technique can help distinguish between normal brain tissue and tumor tissue without the need for a biopsy. Positron emission tomography (PET scan) may be used to detect tumor recurrence or assess tumor activity.[1][8]
The definitive diagnosis of glioblastoma is made through a biopsy, which involves removing a small sample of tissue for examination under a microscope. The biopsy can be performed with a needle before surgery or during surgery to remove the tumor. The tissue sample is sent to a laboratory where specialists examine it to determine if the cells are cancerous and specifically if they are glioblastoma cells. The examination reveals characteristic features such as poorly differentiated cells, high mitotic activity, microvascular proliferation, and necrosis.[2][8]
Modern diagnosis also includes special molecular and genetic testing of the tumor cells. These tests identify specific mutations and markers, such as IDH mutation status, MGMT promoter methylation, and EGFR amplification. This information helps doctors understand the tumor’s behavior, predict how it might respond to treatment, and estimate prognosis. The results guide the creation of a personalized treatment plan tailored to each patient’s specific tumor characteristics.[2][7]
Can Glioblastoma Be Prevented?
Unfortunately, there is no known method to prevent glioblastoma. Because the exact causes of the disease are not fully understood, and most cases occur randomly without identifiable triggers, specific prevention strategies have not been established. Unlike some cancers that can be prevented through lifestyle changes, vaccinations, or screening programs, glioblastoma does not have proven preventive measures.[3][4]
The only well-documented risk factor that is potentially modifiable is exposure to high doses of ionizing radiation. Avoiding unnecessary radiation exposure to the head, particularly in children, may theoretically reduce risk. However, when radiation therapy is medically necessary for treating other conditions, the benefits typically outweigh the small increased risk of developing a brain tumor years later.[2]
For individuals with inherited genetic syndromes known to increase glioblastoma risk, such as Li-Fraumeni syndrome or neurofibromatosis, genetic counseling and regular monitoring may be recommended. However, even in these cases, there are no proven methods to prevent tumor development. Early detection through imaging surveillance in high-risk individuals may allow for earlier intervention, though this approach is not standard practice for most people.[1]
How Glioblastoma Affects the Body
Glioblastoma causes profound changes in the brain’s normal structure and function. The tumor begins with mutations in the DNA of glial cells, causing them to lose their normal regulatory controls. These altered cells multiply rapidly and chaotically, forming a mass that infiltrates and destroys healthy brain tissue. Unlike many cancers that form a distinct lump that can be separated from surrounding tissue, glioblastoma sends tentacle-like projections into adjacent brain areas, making the boundaries between tumor and healthy tissue unclear.[5][10]
One of the hallmark features of glioblastoma is its ability to stimulate the formation of new blood vessels, a process called angiogenesis. The tumor essentially creates its own blood supply to support its rapid growth. However, these newly formed blood vessels are abnormal and leaky, causing fluid to accumulate around the tumor. This fluid accumulation, called peritumoral edema, increases pressure within the skull and contributes to many of the symptoms patients experience.[1]
As the tumor grows, areas within it may outgrow their blood supply, leading to cell death and the formation of necrotic regions. These dead tissue areas are visible on imaging scans and are one of the defining characteristics of glioblastoma. The tumor also triggers inflammation and disrupts the normal electrical activity of the brain, which can lead to seizures.[1][2]
The tumor’s location determines which brain functions are affected. Because different areas of the brain control different functions—such as movement, speech, vision, memory, and personality—the specific symptoms depend on where the tumor is growing. The frontal lobe controls personality, decision-making, and movement; the temporal lobe is involved in memory and speech; the parietal lobe processes sensory information; and the occipital lobe manages vision. Tumors in any of these areas produce distinct patterns of dysfunction.[5]
Glioblastoma cells are highly resistant to the body’s natural defense mechanisms. The tumor can evade the immune system and has an inherent resistance to conventional therapies such as radiation and chemotherapy. The tumor’s cellular composition is also highly heterogeneous, meaning it contains many different types of cells with varying characteristics, which makes it difficult for any single treatment to eliminate all cancer cells. This heterogeneity and adaptability are major reasons why glioblastoma is so difficult to treat and why it almost always recurs despite aggressive therapy.[1][10]
Survival and Prognosis
The prognosis for glioblastoma remains extremely challenging despite advances in treatment. Without any treatment, survival is typically only about three to four months from diagnosis. With current standard treatment including surgery, radiation, and chemotherapy, the median survival time is approximately 12 to 15 months. This means that half of patients live longer than this time, and half live shorter periods.[2][4]
Survival rates vary significantly depending on several factors. In the first year after diagnosis, approximately 40 percent of patients are still alive, but this drops to about 17 percent by the second year. The five-year survival rate for glioblastoma is particularly low, ranging from 5 to 10 percent. Only about 6.9 percent of patients survive five years after diagnosis, and even fewer survive beyond that timeframe.[1][4]
Several factors influence prognosis. Younger patients generally have better outcomes than older patients. The extent of surgical resection matters—patients who have more complete tumor removal tend to survive longer, though only by a few months. Overall health and functional status at diagnosis also play important roles, with healthier, more active patients typically doing better than those with poor performance status.[11]
Molecular characteristics of the tumor are increasingly recognized as important predictors of outcome. Tumors with certain genetic features, such as IDH mutations or MGMT promoter methylation, tend to respond better to treatment and are associated with improved survival. Some studies have identified distinct molecular subtypes of glioblastoma that respond differently to therapies, with certain subtypes having better prognoses than others.[7][10]
Despite maximum treatment, glioblastoma almost always recurs. The tumor’s ability to infiltrate surrounding brain tissue means that microscopic cancer cells remain even after seemingly complete surgical removal and aggressive radiation and chemotherapy. When the tumor returns, treatment options become more limited, and survival time is typically shorter than after the initial diagnosis.[3]
